Scientific and medical disciplines across the broad spectrum of research and clinical
applications are looking to molecular imaging as a key element in advancing knowledge …

David Mankoff, MD, PhD, associate editor for The Journal of Nuclear Medicine, talked with
Mark Mintun, MD, about Mintun's career as a leader in molecular imaging in academia and …

SNMMI is excited to kick off the new year with the 2016 Mid-Winter Meeting, to be held
January 28–31 at the Hilton Walt Disney World Hotel in Orlando, FL. This 4-day event will …

Arecent meeting convened by the US Food and Drug Administration (FDA) provides
optimism for the introduction of new molecular imaging agents for clinical use, particularly for …

The SNM Center for Molecular Imaging Innovation and Translation (CMIIT) is sponsoring a 1-
d Molecular Imaging Summit at the SNM Mid-Winter Meeting on Thursday, January 26 …

Conclusion Molecular imaging continues to have an important role in drug development and
basic discovery in neuroscience. Clinical applications in neurodegenerative disease are set …

The objective of this activity is to spotlight the clinical utility of positron emission tomographic
(PET) scanning in the early detection and clinical management of dementias such as …

The prestigious annual Eugene P. Pendergrass New Horizons Lecture was given on
November 29 by Michael E. Phelps, PhD, Norton Simon Professor and chair of the …

January 22–25, 2015 SNMMI 2015 Mid-Winter Meeting Highlighting advances in hybrid
imaging, SPECT and Amyloid PET, role of PET/MRI in molecular imaging, targeted …

Dementia is a highly prevalent problem causing considerable disability and mortality and
exacting great costs to individuals, their families, and society. The 4 most common …